CJC-1295 is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH) studied for its effects on growth hormone (GH) and insulin-like growth factor-1 (IGF-1) signaling.
This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, diagnostic use, or veterinary applications. Purchasers are responsible for ensuring compliance with all applicable laws and regulations regarding the handling and use of research materials.
CJC-1295 is a modified GHRH analog designed to extend biological activity through binding with endogenous albumin. Research has investigated its ability to produce sustained increases in GH and IGF-1, while examining the relationship between GHRH receptor signaling, pituitary GH secretion, and downstream IGF-1 activity.
For a research-use-only catalog, CJC-1295 is suitable for research involving:
Purity: ≥98%